An EBV-positive lymphoproliferative disorder after therapy with alemtuzumab.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Ghobrial, IM; Otteman, LA; White, WL

Published Date

  • December 25, 2003

Published In

Volume / Issue

  • 349 / 26

Start / End Page

  • 2570 - 2572

PubMed ID

  • 14695424

Pubmed Central ID

  • 14695424

Electronic International Standard Serial Number (EISSN)

  • 1533-4406

Digital Object Identifier (DOI)

  • 10.1056/NEJM200312253492622

Language

  • eng

Conference Location

  • United States